Modified Fluorinated Nucleoside Analogues

Patent No. EP1633766 (titled "Modified Fluorinated Nucleoside Analogues") was filed by Gilead Pharmasset on Apr 21, 2004. The application was issued on Mar 6, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GILLARDDec 5, 2019ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1633766

GILEAD PHARMASSET
Application Number
EP04775900A
Filing Date
Apr 21, 2004
Status
Revoked
Jul 24, 2020
Publication Date
Mar 6, 2019